Apelin directly inhibits insulin secretion in pancreatic beta-cells via activation of PI3-kinase-dependent PDE3B and subsequent suppression of cAMP levels.
No takes yet. Share an insight, caveat, or question.
Rodent data on apelin's insulin suppression warrant no clinical change; leaves open its role in human beta-cell dysfunction.
Guo et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: